|
|
|
|
|
|
|
|
|
|
Previous: GENEREX BIOTECHNOLOGY CORP, 10-K, EX-23.1, 2000-10-30 |
Next: MAIN STREET BANCORP INC, 8-K, 2000-10-30 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> JUL-31-2000
<PERIOD-END> JUL-31-2000
<CASH> 3,204,905
<SECURITIES> 3,966,263
<RECEIVABLES> 16,138
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 7,286,347
<PP&E> 2,605,038
<DEPRECIATION> 209,171
<TOTAL-ASSETS> 10,341,270
<CURRENT-LIABILITIES> 1,213,686
<BONDS> 712,559
0
1
<COMMON> 30,451,393
<OTHER-SE> (54,118)
<TOTAL-LIABILITY-AND-EQUITY> 10,341,270
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 9,043,956
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (195,003)
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (8,841,047)
<EPS-BASIC> (0.58)
<EPS-DILUTED> (0.58)
</TABLE>
|
|